Overview

FEcal Microbiota Transplantation

Status:
Unknown status

Trial end date:
2020-12-31

Target enrollment:

Participant gender:

Summary

The primary objective will be to evaluate effectiveness, safety and acceptability of FMT on depressive symptoms at 2 months follow-up in SZ patients with resistant MD.

Phase:

N/A

Details

Lead Sponsor:

Assistance Publique Hopitaux De Marseille